0.9601
price down icon13.50%   -0.1499
after-market Handel nachbörslich: .97 0.0099 +1.03%
loading
Schlusskurs vom Vortag:
$1.11
Offen:
$1.07
24-Stunden-Volumen:
84,208
Relative Volume:
0.20
Marktkapitalisierung:
$2.17M
Einnahmen:
$31,800
Nettoeinkommen (Verlust:
$-37.83M
KGV:
-1.3523
EPS:
-0.71
Netto-Cashflow:
$-30.64M
1W Leistung:
-15.04%
1M Leistung:
-39.23%
6M Leistung:
-97.51%
1J Leistung:
-98.66%
1-Tages-Spanne:
Value
$0.9597
$1.07
1-Wochen-Bereich:
Value
$0.9597
$1.19
52-Wochen-Spanne:
Value
$0.9597
$124.80

Eyenovia Inc Stock (EYEN) Company Profile

Name
Firmenname
Eyenovia Inc
Name
Telefon
813-766-9539
Name
Adresse
295 MADISON AVENUE,, NEW YORK, NY
Name
Mitarbeiter
57
Name
Twitter
@eyenovia
Name
Nächster Verdiensttermin
2025-03-26
Name
Neueste SEC-Einreichungen
Name
EYEN's Discussions on Twitter

Vergleichen Sie EYEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
EYEN
Eyenovia Inc
0.9601 2.17M 31,800 -37.83M -30.64M -0.71
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 125.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 65.79B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 35.18B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 32.67B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 26.46B 3.81B -644.79M -669.77M -6.24

Eyenovia Inc Stock (EYEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-11-18 Herabstufung H.C. Wainwright Buy → Neutral
2021-03-01 Eingeleitet Northland Capital Outperform
2020-02-03 Herabstufung Oppenheimer Outperform → Perform

Eyenovia Inc Aktie (EYEN) Neueste Nachrichten

pulisher
Apr 01, 2025

Eyenovia Inc expected to post a loss of $7.20 a shareEarnings Preview - TradingView

Apr 01, 2025
pulisher
Mar 31, 2025

Eyenovia Delays Yearly Report Filing - TipRanks

Mar 31, 2025
pulisher
Mar 26, 2025

Deal Watch: Eyenovia Looks At New Direction In Proposed Merger With Betaliq - insights.citeline.com

Mar 26, 2025
pulisher
Mar 21, 2025

Eyenovia falls on plans to seek reverse merger - MSN

Mar 21, 2025
pulisher
Mar 21, 2025

Eyenovia Enters Into Non-Binding Letter of Intent to Effect Reverse Merger With Betaliq - VisionMonday.com

Mar 21, 2025
pulisher
Mar 20, 2025

Eyenovia And Betaliq Announce Potential Reverse Merger - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia Shares Drop 14% Amid Betaliq Merger Talks - Yahoo

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia stock falls on reverse merger plans (EYEN:NASDAQ) - Seeking Alpha

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia falls after plans to merge with private firm Betaliq - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia Plans All-Stock Reverse Merger With Betaliq - MarketWatch

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia and Betaliq Explore Merger to Form New Ophthalmic Company Combining Innovative Drug Delivery Technologies for Glaucoma Treatment - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

Strategic Merger Alert: Eyenovia and Betaliq Join Forces to Revolutionize Eye Care Delivery - StockTitan

Mar 20, 2025
pulisher
Mar 15, 2025

EYENOVIA Earnings Preview: Recent $EYEN Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 15, 2025
pulisher
Mar 07, 2025

Eyenovia, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Feb 28, 2025

Eyenovia regains compliance with Nasdaq - MSN

Feb 28, 2025
pulisher
Feb 27, 2025

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements - GlobeNewswire

Feb 27, 2025
pulisher
Feb 26, 2025

Eyenovia Shares Surge After Regaining Nasdaq Compliance: What's Going On? - Benzinga

Feb 26, 2025
pulisher
Feb 26, 2025

Eyenovia regains Nasdaq compliance, eyes strategic options By Investing.com - Investing.com Canada

Feb 26, 2025
pulisher
Feb 26, 2025

Eyenovia regains Nasdaq compliance, eyes strategic options - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

Eyenovia shareholders approve reverse stock split and additional stock reserve - MSN

Feb 26, 2025
pulisher
Feb 26, 2025

Eyenovia Escapes Delisting Threat: What's Next for the Optejet Developer? - StockTitan

Feb 26, 2025
pulisher
Feb 26, 2025

Eyenovia regains Nasdaq compliance with stock bid price By Investing.com - Investing.com Australia

Feb 26, 2025
pulisher
Feb 25, 2025

Eyenovia regains Nasdaq compliance with stock bid price - Investing.com

Feb 25, 2025
pulisher
Feb 25, 2025

Eyenovia, Inc. Announces Debt Restructuring, Including Amendment to Senior Secured Debt to Improve Liquidity - Vision Monday

Feb 25, 2025
pulisher
Feb 24, 2025

Eyenovia defers debt payments to bolster liquidity By Investing.com - Investing.com Nigeria

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia announces debt restructuring, improving cash runway - MSN

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia, Inc. Announces Debt Restructuring Including - GlobeNewswire

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia defers loan payments, may convert debt to equity By Investing.com - Investing.com Canada

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia defers loan payments, may convert debt to equity - Investing.com India

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia defers debt payments to bolster liquidity - Investing.com India

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Eyenovia, Inc. Announces Amendment to Senior Secured Convertible Debt to Enhance Liquidity and Support Optejet® Development - Nasdaq

Feb 24, 2025
pulisher
Feb 24, 2025

Can This Biotech's Debt Restructuring Lead to a Strategic Sale? - StockTitan

Feb 24, 2025
pulisher
Feb 11, 2025

FY2025 EPS Estimates for Eyenovia Boosted by HC Wainwright - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Eyenovia Inc’s (EYEN) Stock: A -58.29% Simple Moving Average for the Past 20 Days - The News Heater

Feb 10, 2025
pulisher
Feb 08, 2025

Wainwright maintains neutral Eyenovia stock, $2 target - MSN

Feb 08, 2025
pulisher
Feb 06, 2025

Wainwright maintains neutral Eyenovia stock, $2 target By Investing.com - Investing.com Canada

Feb 06, 2025
pulisher
Feb 05, 2025

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - GlobeNewswire

Feb 05, 2025
pulisher
Feb 05, 2025

The Attractiveness of Investing In Eyenovia Inc (EYEN) is Growing - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Eyenovia, Inc. Announces Progress on Next-Generation User-Filled Optejet Dispensing Device - Marketscreener.com

Feb 05, 2025
pulisher
Feb 05, 2025

Revolutionary Eye Drop Spray Shows Perfect Precision: Eyenovia's Game-Changing Solution for Millions - StockTitan

Feb 05, 2025
pulisher
Feb 05, 2025

Eyenovia, Inc. Advances Development of User-Filled Optejet Device for Enhanced Ophthalmic Treatment - Nasdaq

Feb 05, 2025
pulisher
Feb 01, 2025

Eyenovia enacts reverse stock split to meet Nasdaq requirements By Investing.com - Investing.com Australia

Feb 01, 2025
pulisher
Feb 01, 2025

Eyenovia enacts reverse stock split to meet Nasdaq requirements - Investing.com

Feb 01, 2025

Finanzdaten der Eyenovia Inc-Aktie (EYEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Eyenovia Inc-Aktie (EYEN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Rowe Michael M
Chief Executive Officer
Aug 26 '24
Buy
0.57
50,000
28,500
82,927
Grant Stuart M.
10% Owner
Jul 02 '24
Buy
0.66
1,515,151
1,000,000
10,914,153
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Kapitalisierung:     |  Volumen (24h):